back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-04-29 16:06 Tx date 2025-03-13 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
$-47,500
-250,000 vol $0.19 each |
2,465,727 | |
| Filed 2025-04-29 16:00 Tx date 2016-12-21 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$262,500
+175,000 vol $1.50 each |
275,000 | |
| Filed 2025-04-29 15:19 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2025-04-29 15:02 Tx date 2018-11-29 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+175,000 vol |
939,480 | |
| Filed 2025-04-29 15:00 Tx date 2018-03-23 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+100,000 vol |
764,480 | |
| Filed 2025-04-29 14:58 Tx date 2018-11-29 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-175,000 vol |
0 | |
| Filed 2025-04-29 14:56 Tx date 2018-03-23 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-100,000 vol |
0 | |
| Filed 2025-04-29 14:51 Tx date 2016-12-28 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$876,720
+584,480 vol $1.50 each |
664,480 | |
| Filed 2025-03-27 11:50 Tx date 2018-11-29 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
97 - Other
|
+175,000 vol |
||
| Filed 2025-03-27 11:48 Tx date 2018-11-29 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
97 - Other
|
-175,000 vol |
||
| Filed 2025-03-27 11:46 Tx date 2018-03-23 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
97 - Other
|
+100,000 vol |
||
| Filed 2025-03-27 11:43 Tx date 2018-03-23 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
97 - Other
|
-100,000 vol |
||
| Filed 2025-03-27 11:37 Tx date 2016-12-28 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
97 - Other
|
$876,720
+584,480 vol $1.50 each |
||
| Filed 2017-01-03 13:05 Tx date 2016-12-28 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
97 - Other
|
$876,720
+584,480 vol $1.50 each |
||
| Filed 2016-12-23 14:30 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-23 14:24 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-27 11:56 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,465
+34,725 vol $0.071 each |
2,378,485 | |
| Filed 2025-03-27 11:55 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$298.55
+4,265 vol $0.07 each |
2,343,760 | |
| Filed 2025-03-27 11:55 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,733
+731,368 vol $0.068 each |
2,339,495 | |
| Filed 2025-03-27 11:54 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,556
+68,000 vol $0.067 each |
1,608,127 | |
| Filed 2025-03-27 11:53 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,045
+100,647 vol $0.07 each |
1,540,127 | |
| Filed 2025-03-27 11:52 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,000
+500,000 vol $0.064 each |
1,439,480 | |
| Filed 2025-03-27 11:50 Tx date 2018-11-29 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
97 - Other
|
+175,000 vol |
939,480 | |
| Filed 2025-03-27 11:48 Tx date 2018-11-29 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
97 - Other
|
-175,000 vol |
0 | |
| Filed 2025-03-27 11:46 Tx date 2018-03-23 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
97 - Other
|
+100,000 vol |
764,480 | |
| Filed 2025-03-27 11:43 Tx date 2018-03-23 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
97 - Other
|
-100,000 vol |
0 | |
| Filed 2025-03-27 11:37 Tx date 2016-12-28 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
97 - Other
|
$876,720
+584,480 vol $1.50 each |
664,480 | |
| Filed 2025-03-27 11:32 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,478
+1,300 vol $2.68 each |
181,000 | |
| Filed 2025-03-27 11:30 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,528
+1,700 vol $2.66 each |
179,700 | |
| Filed 2025-03-27 11:29 Tx date 2017-08-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,955
+5,000 vol $2.39 each |
178,000 | |
| Filed 2025-03-27 11:26 Tx date 2017-08-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,254
+5,000 vol $2.25 each |
173,000 | |
| Filed 2025-03-27 11:23 Tx date 2016-11-16 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,504
+8,800 vol $1.08 each |
168,000 | |
| Filed 2025-03-27 11:21 Tx date 2016-11-15 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$65,400
+60,000 vol $1.09 each |
159,200 | |
| Filed 2025-03-27 11:18 Tx date 2016-11-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,000
+10,000 vol $1.10 each |
99,200 | |
| Filed 2025-03-27 11:17 Tx date 2016-11-11 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,920
+27,200 vol $1.10 each |
89,200 | |
| Filed 2025-03-27 11:14 Tx date 2016-11-09 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,500
+25,000 vol $1.10 each |
62,000 | |
| Filed 2025-03-27 11:11 Tx date 2016-10-27 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,520
+19,000 vol $1.08 each |
37,000 | |
| Filed 2025-03-27 11:08 Tx date 2016-10-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+10,000 vol $1.05 each |
18,000 | |
| Filed 2025-03-27 11:04 Tx date 2016-10-18 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,320
+8,000 vol $1.04 each |
8,000 | |
| Filed 2025-03-27 11:01 Tx date 2016-04-21 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: IRA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-27 10:57 Tx date 2016-04-21 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Jeffrey M. Rowe Living Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
80,000 | ||
| Filed 2025-03-27 10:52 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-13 13:16 Tx date 2016-11-16 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,504
+8,800 vol $1.08 each |
||
| Filed 2018-08-13 13:14 Tx date 2016-11-15 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$65,400
+60,000 vol $1.09 each |
||
| Filed 2018-08-13 13:13 Tx date 2016-11-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,000
+10,000 vol $1.10 each |
||
| Filed 2018-08-13 13:11 Tx date 2016-11-11 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,920
+27,200 vol $1.10 each |
||
| Filed 2018-08-13 13:10 Tx date 2016-11-09 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,500
+25,000 vol $1.10 each |
||
| Filed 2018-08-13 13:08 Tx date 2016-10-27 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,520
+19,000 vol $1.08 each |
||
| Filed 2018-08-13 13:06 Tx date 2016-10-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+10,000 vol $1.05 each |
||
| Filed 2018-04-17 12:44 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,478
+1,300 vol $2.68 each |
||
| Filed 2018-04-17 12:43 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,528
+1,700 vol $2.66 each |
||
| Filed 2018-04-17 12:40 Tx date 2017-08-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,955
+5,000 vol $2.39 each |
||
| Filed 2018-04-17 12:38 Tx date 2017-08-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,254
+5,000 vol $2.25 each |
||
| Filed 2017-09-01 12:47 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,808
+1,300 vol $2.16 each |
||
| Filed 2017-09-01 12:46 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,655
+1,700 vol $2.15 each |
||
| Filed 2017-09-01 12:44 Tx date 2017-08-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,650
+5,000 vol $1.93 each |
||
| Filed 2017-09-01 12:42 Tx date 2017-08-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,150
+5,000 vol $1.83 each |
||
| Filed 2017-01-03 13:05 Tx date 2016-12-28 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
97 - Other
|
$876,720
+584,480 vol $1.50 each |
||
| Filed 2016-04-27 16:04 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-20 12:04 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,900
+100,000 vol $0.069 each |
261,900 | |
| Filed 2025-03-19 13:48 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$48,998
+699,980 vol $0.07 each |
3,200,030 | |
| Filed 2025-03-19 13:46 Tx date 2024-06-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$46,528
+299,993 vol $0.1551 each |
2,000,050 | |
| Filed 2025-03-19 13:45 Tx date 2024-06-11 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$75,100
+500,000 vol $0.1502 each |
1,700,057 | |
| Filed 2025-03-19 13:44 Tx date 2024-06-10 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,941
+200,007 vol $0.1497 each |
1,200,057 | |
| Filed 2025-03-19 13:00 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Jordan, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,600
+300,000 vol $0.062 each |
300,000 | |
| Filed 2025-03-19 13:00 Tx date 2025-01-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Jordan, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-18 17:48 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Blair, Tony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,000
+500,000 vol $0.06 each |
900,000 | |
| Filed 2025-03-18 17:45 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,500
+100,000 vol $0.065 each |
2,925,000 | |
| Filed 2025-03-18 17:44 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,350
+50,000 vol $0.067 each |
2,825,000 | |
| Filed 2025-03-18 17:43 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,700
+100,000 vol $0.067 each |
2,775,000 | |
| Filed 2025-03-18 17:43 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,700
+100,000 vol $0.067 each |
2,675,000 | |
| Filed 2025-03-18 17:42 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,500
+50,000 vol $0.07 each |
2,575,000 | |
| Filed 2025-03-18 17:41 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,900
+100,000 vol $0.069 each |
2,525,000 | |
| Filed 2025-03-18 17:38 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
MacLeod, Christopher
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,437
+143,000 vol $0.059 each |
143,000 | |
| Filed 2025-03-18 17:31 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,759
+179,328 vol $0.06 each |
1,000,000 | |
| Filed 2025-03-18 17:30 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,509
+191,817 vol $0.06 each |
820,672 | |
| Filed 2025-03-18 17:29 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,893
+118,855 vol $0.058 each |
628,855 | |
| Filed 2025-03-18 17:29 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$540.00
+10,000 vol $0.054 each |
510,000 | |
| Filed 2025-02-24 16:39 Tx date 2025-02-21 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+200,000 vol $0.12 each |
2,200,000 | |
| Filed 2025-01-03 14:28 Tx date 2025-01-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Jordan, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$700,000
+5,000,000 vol $0.14 each |
5,000,000 | |
| Filed 2025-01-03 14:25 Tx date 2025-01-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Jordan, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-13 16:49 Tx date 2024-11-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Blair, Tony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,450
+150,000 vol $0.123 each |
400,000 | |
| Filed 2024-11-13 16:47 Tx date 2024-11-11 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Blair, Tony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,000
+400,000 vol $0.13 each |
3,400,000 | |
| Filed 2024-11-13 16:41 Tx date 2024-11-11 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
DeHaan-Fullerton, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$65,000
+500,000 vol $0.13 each |
1,000,000 | |
| Filed 2024-11-12 11:04 Tx date 2024-11-11 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,100
+100,000 vol $0.121 each |
2,425,000 | |
| Filed 2024-11-12 11:00 Tx date 2024-11-11 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,200
+100,000 vol $0.122 each |
500,000 | |
| Filed 2024-11-12 10:53 Tx date 2024-11-11 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,065
+289,800 vol $0.121 each |
1,500,050 | |
| Filed 2024-11-12 10:52 Tx date 2024-11-11 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,224
+210,200 vol $0.12 each |
1,210,250 | |
| Filed 2024-09-05 14:54 Tx date 2024-09-05 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,500
+100,000 vol $0.125 each |
400,000 | |
| Filed 2024-08-28 16:31 Tx date 2024-08-28 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,900
+100,000 vol $0.129 each |
2,325,000 | |
| Filed 2024-08-20 16:02 Tx date 2024-08-20 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Blair, Tony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,199
+100,000 vol $0.142 each |
250,000 | |
| Filed 2024-05-17 15:52 Tx date 2024-05-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,500
+50,000 vol $0.17 each |
2,225,000 | |
| Filed 2024-05-17 15:51 Tx date 2024-05-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,950
+50,000 vol $0.179 each |
2,175,000 | |
| Filed 2024-05-17 10:26 Tx date 2024-05-16 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,600
+25,000 vol $0.184 each |
2,125,000 | |
| Filed 2024-05-16 10:40 Tx date 2024-05-13 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Donato, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$350,000
+2,500,000 vol $0.14 each |
2,500,000 | |
| Filed 2024-05-15 17:36 Tx date 2024-05-14 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,283
+30,594 vol $0.14 each |
2,100,000 | |
| Filed 2024-05-15 17:36 Tx date 2024-05-14 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,697
+19,406 vol $0.139 each |
2,069,406 | |
| Filed 2024-05-15 17:21 Tx date 2023-03-16 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Donato, Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-05-15 09:34 Tx date 2024-05-13 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Blair, Tony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,000
+150,000 vol $0.14 each |
150,000 | |
| Filed 2024-05-15 09:27 Tx date 2024-05-13 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,000
+100,000 vol $0.14 each |
2,050,000 | |
| Filed 2024-05-13 17:33 Tx date 2024-05-13 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,199
+100,000 vol $0.142 each |
300,000 | |
| Filed 2023-12-18 09:30 Tx date 2023-12-15 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,500
+100,000 vol $0.165 each |
1,950,000 | |
| Filed 2023-11-20 16:36 Tx date 2023-11-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,600
+100,000 vol $0.166 each |
1,850,000 | |
| Filed 2023-11-17 16:55 Tx date 2023-11-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,600
+100,000 vol $0.166 each |
200,000 | |
| Filed 2023-11-16 16:42 Tx date 2023-11-15 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,949
+150,000 vol $0.173 each |
1,750,000 | |
| Filed 2023-11-14 16:42 Tx date 2023-11-07 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$400,000
+2,000,000 vol $0.20 each |
2,000,000 | |
| Filed 2023-11-09 16:13 Tx date 2023-11-07 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$380,000
+2,000,000 vol $0.19 each |
||
| Filed 2023-11-09 16:13 Tx date 2023-11-07 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$380,000
+2,000,000 vol $0.19 each |
2,000,000 | |
| Filed 2023-11-09 16:12 Tx date 2023-11-06 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-09 16:11 Tx date 2023-11-06 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000,050 | ||
| Filed 2023-05-26 14:48 Tx date 2023-05-26 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,080
+100,000 vol $0.1908 each |
100,000 | |
| Filed 2023-05-25 18:15 Tx date 2023-05-25 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,340
+100,000 vol $0.1934 each |
1,600,000 | |
| Filed 2022-12-13 19:42 Tx date 2022-12-09 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Nichols, Pamela Ann
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$43,971
+231,431 vol $0.19 each |
231,431 | |
| Filed 2022-12-13 19:40 Tx date 2022-08-23 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Nichols, Pamela Ann
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-13 19:37 Tx date 2022-12-09 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Whelan, Sean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$219,859
+1,157,153 vol $0.19 each |
1,957,153 | |
| Filed 2022-12-13 19:33 Tx date 2022-12-09 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$278,488
+1,465,727 vol $0.19 each |
11,728,227 | |
| Filed 2022-12-13 19:30 Tx date 2022-12-09 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$278,488
+1,465,727 vol $0.19 each |
2,515,727 | |
| Filed 2022-12-13 19:25 Tx date 2022-12-09 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
MacLeod, Christopher
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$278,488
+1,465,727 vol $0.19 each |
2,440,727 | |
| Filed 2022-12-13 19:20 Tx date 2022-12-09 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$278,488
+1,465,727 vol $0.19 each |
2,265,727 | |
| Filed 2022-12-13 19:14 Tx date 2022-12-09 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$278,488
+1,465,727 vol $0.19 each |
2,615,727 | |
| Filed 2022-10-06 10:15 Tx date 2022-10-04 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$880,000
+4,000,000 vol $0.22 each |
14,000,000 | |
| Filed 2022-06-13 18:46 Tx date 2022-06-13 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
DeHaan-Fullerton, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2022-06-13 18:45 Tx date 2022-06-13 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
DeHaan-Fullerton, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-13 18:21 Tx date 2022-06-13 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Blair, Tony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
3,000,000 | ||
| Filed 2022-06-13 18:18 Tx date 2022-06-13 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Blair, Tony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-02 14:21 Tx date 2022-02-25 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Lock, Adrian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+2,000,000 vol |
3,000,000 | |
| Filed 2021-11-23 15:12 Tx date 2021-11-18 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$112,500
+250,000 vol $0.45 each |
1,500,000 | |
| Filed 2021-11-04 17:57 Tx date 2021-10-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Lock, Adrian
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
| Filed 2021-10-07 17:35 Tx date 2021-10-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
10,000,000 | ||
| Filed 2021-10-07 17:34 Tx date 2021-10-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-15 12:43 Tx date 2021-09-13 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Whelan, Sean
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
800,000 | ||
| Filed 2021-09-15 12:42 Tx date 2021-09-13 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Whelan, Sean
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-07-02 18:07 Tx date 2021-06-30 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-447,343.125
-543,750 vol $0.82 each |
0 | |
| Filed 2021-07-02 18:01 Tx date 2021-06-30 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$125,062
+543,750 vol $0.23 each |
543,750 | |
| Filed 2021-07-02 17:59 Tx date 2021-06-30 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-543,750 vol |
10,262,500 | |
| Filed 2021-06-18 13:10 Tx date 2021-06-15 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-116,737.50
-125,000 vol $0.93 each |
1,250,000 | |
| Filed 2021-06-18 13:01 Tx date 2021-06-15 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$32,500
+125,000 vol $0.26 each |
1,375,000 | |
| Filed 2021-06-18 12:59 Tx date 2021-06-15 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-125,000 vol |
1,050,000 | |
| Filed 2021-06-18 12:51 Tx date 2021-05-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-96,987.50
-125,000 vol $0.78 each |
1,250,000 | |
| Filed 2021-05-21 22:01 Tx date 2021-05-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-96,987.50
-125,000 vol $0.78 each |
||
| Filed 2021-06-03 10:35 Tx date 2021-06-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-2,000,000 vol |
12,000,000 | |
| Filed 2021-06-03 10:34 Tx date 2021-06-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$274,562
+1,193,750 vol $0.23 each |
3,193,750 | |
| Filed 2021-06-03 10:33 Tx date 2021-06-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$380,000
+2,000,000 vol $0.19 each |
2,000,000 | |
| Filed 2021-06-03 10:30 Tx date 2021-06-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-617,465.60
-771,832 vol $0.80 each |
0 | |
| Filed 2021-06-03 10:29 Tx date 2021-06-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,132,858.71
-1,398,591 vol $0.81 each |
771,832 | |
| Filed 2021-06-03 10:28 Tx date 2021-06-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-531,907.76
-648,668 vol $0.82 each |
2,170,423 | |
| Filed 2021-06-03 10:27 Tx date 2021-06-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-257,588.01
-310,347 vol $0.83 each |
2,819,091 | |
| Filed 2021-06-03 10:25 Tx date 2021-06-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-41,522.04
-49,431 vol $0.84 each |
3,129,438 | |
| Filed 2021-06-03 10:24 Tx date 2021-06-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,648.85
-14,881 vol $0.85 each |
3,178,869 | |
| Filed 2021-06-03 10:23 Tx date 2021-06-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$274,562
+1,193,750 vol $0.23 each |
||
| Filed 2021-06-03 10:22 Tx date 2021-06-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-1,193,750 vol |
10,806,250 | |
| Filed 2021-06-03 10:20 Tx date 2021-06-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$380,000
+2,000,000 vol $0.19 each |
||
| Filed 2021-06-03 10:19 Tx date 2021-06-01 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-2,000,000 vol |
||
| Filed 2021-05-21 22:01 Tx date 2021-05-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-96,987.50
-125,000 vol $0.78 each |
1,250,000 | |
| Filed 2021-05-21 21:56 Tx date 2021-05-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$32,500
+125,000 vol $0.26 each |
1,375,000 | |
| Filed 2021-05-21 21:54 Tx date 2021-05-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-125,000 vol |
1,175,000 | |
| Filed 2021-05-14 19:06 Tx date 2021-05-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
MacLeod, Christopher
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
975,000 | |
| Filed 2021-05-14 18:47 Tx date 2021-05-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,150,000 | |
| Filed 2021-05-14 13:01 Tx date 2021-05-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
800,000 | |
| Filed 2021-05-13 19:47 Tx date 2021-05-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
1,300,000 | |
| Filed 2021-05-13 15:07 Tx date 2021-05-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Wolfenberg, Christopher Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
800,000 | |
| Filed 2021-05-13 14:59 Tx date 2020-08-06 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Wolfenberg, Christopher Michael
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-04 19:22 Tx date 2021-05-03 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cotter, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,610.64
-19,444 vol $1.06 each |
0 | |
| Filed 2021-05-04 19:21 Tx date 2021-05-03 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cotter, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$916.63
+8,333 vol $0.11 each |
19,444 | |
| Filed 2021-05-04 19:19 Tx date 2021-05-03 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cotter, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$2,111
+11,111 vol $0.19 each |
11,111 | |
| Filed 2021-05-04 19:18 Tx date 2021-05-03 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cotter, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-916.63
-8,333 vol $0.11 each |
3,122,224 | |
| Filed 2021-05-04 19:17 Tx date 2021-05-03 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cotter, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,111.09
-11,111 vol $0.19 each |
3,130,557 | |
| Filed 2021-04-16 13:58 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cotter, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-67,472.6244
-58,332 vol $1.16 each |
0 | |
| Filed 2021-04-16 13:56 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cotter, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$2,750
+25,000 vol $0.11 each |
58,332 | |
| Filed 2021-04-16 13:55 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cotter, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,333
+33,332 vol $0.19 each |
33,332 | |
| Filed 2021-04-16 13:53 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cotter, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,750
-25,000 vol $0.11 each |
3,141,668 | |
| Filed 2021-04-16 13:51 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cotter, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,333.08
-33,332 vol $0.19 each |
3,166,668 | |
| Filed 2021-04-15 18:51 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-867,525
-750,000 vol $1.16 each |
625,000 | |
| Filed 2021-04-15 18:43 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$100,000
+625,000 vol $0.16 each |
1,250,000 | |
| Filed 2021-04-15 18:40 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-100,000
-625,000 vol $0.16 each |
0 | |
| Filed 2021-04-15 18:37 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-867,525
-750,000 vol $1.16 each |
||
| Filed 2021-04-15 18:36 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$65,000
+250,000 vol $0.26 each |
1,375,000 | |
| Filed 2021-04-15 18:35 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$35,000
+100,000 vol $0.35 each |
1,125,000 | |
| Filed 2021-04-15 18:33 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$45,000
+100,000 vol $0.45 each |
1,025,000 | |
| Filed 2021-04-15 18:31 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$55,000
+100,000 vol $0.55 each |
925,000 | |
| Filed 2021-04-15 18:30 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$65,000
+100,000 vol $0.65 each |
825,000 | |
| Filed 2021-04-15 18:29 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$75,000
+100,000 vol $0.75 each |
725,000 | |
| Filed 2021-04-15 18:27 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-65,000
-250,000 vol $0.26 each |
500,000 | |
| Filed 2021-04-15 18:25 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-35,000
-100,000 vol $0.35 each |
750,000 | |
| Filed 2021-04-15 18:24 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-45,000
-100,000 vol $0.45 each |
850,000 | |
| Filed 2021-04-15 18:22 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-55,000
-100,000 vol $0.55 each |
950,000 | |
| Filed 2021-04-15 18:20 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-65,000
-100,000 vol $0.65 each |
1,050,000 | |
| Filed 2021-04-15 18:17 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-75,000
-100,000 vol $0.75 each |
1,150,000 | |
| Filed 2021-04-15 17:35 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-931,143.50
-805,000 vol $1.16 each |
1,459,580 | |
| Filed 2021-04-15 17:34 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$57,950
+305,000 vol $0.19 each |
2,264,580 | |
| Filed 2021-04-15 17:30 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$215,000
+500,000 vol $0.43 each |
1,959,580 | |
| Filed 2021-04-15 17:28 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-57,950
-305,000 vol $0.19 each |
4,145,000 | |
| Filed 2021-04-15 17:27 Tx date 2021-04-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-215,000
-500,000 vol $0.43 each |
4,450,000 | |
| Filed 2021-02-08 20:27 Tx date 2021-01-10 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cotter, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-76,000
-50,000 vol $1.52 each |
3,200,000 | |
| Filed 2021-02-08 14:14 Tx date 2020-07-09 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
MacLeod, Christopher
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
175,000 | ||
| Filed 2021-02-08 14:13 Tx date 2021-02-03 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
MacLeod, Christopher
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,047.04
-6,400 vol $1.10 each |
0 | |
| Filed 2021-02-08 14:12 Tx date 2020-07-09 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
MacLeod, Christopher
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,400 | ||
| Filed 2021-02-08 10:10 Tx date 2021-01-10 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
$-532,000
-350,000 vol $1.52 each |
150,000 | |
| Filed 2021-02-05 18:38 Tx date 2021-01-10 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-567,112
-373,100 vol $1.52 each |
0 | |
| Filed 2021-01-05 15:32 Tx date 2020-12-31 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,760,000
+12,000,000 vol $0.23 each |
14,000,000 | |
| Filed 2021-01-05 15:23 Tx date 2020-12-31 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Cotter, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$690,000
+3,000,000 vol $0.23 each |
3,250,000 | |
| Filed 2021-01-05 10:54 Tx date 2020-12-31 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Schilk, Michael Henry
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Options
50 - Grant of options
|
$345,000
+1,500,000 vol $0.23 each |
2,300,000 | |
| Filed 2021-01-05 09:18 Tx date 2020-12-31 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Herbst, Bruk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$690,000
+3,000,000 vol $0.23 each |
4,137,004 | |
| Filed 2021-01-04 12:01 Tx date 2020-09-29 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$33,000
+300,000 vol $0.11 each |
2,450,000 | |
| Filed 2021-01-04 11:59 Tx date 2020-12-31 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$575,000
+2,500,000 vol $0.23 each |
4,650,000 | |
| Filed 2020-08-20 18:50 Tx date 2020-08-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Cotter, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2020-08-20 18:44 Tx date 2020-08-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Cotter, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-07 07:54 Tx date 2020-07-07 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$100,000
+625,000 vol $0.16 each |
625,000 | |
| Filed 2020-07-06 13:05 Tx date 2019-08-16 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-06 13:03 Tx date 2020-07-01 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,000
+625,000 vol $0.16 each |
625,000 | |
| Filed 2020-07-06 12:56 Tx date 2019-08-16 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-24 10:23 Tx date 2020-06-16 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
2,000,000 | ||
| Filed 2020-06-24 10:20 Tx date 2020-06-16 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Cohen, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-03-18 11:20 Tx date 2020-03-13 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Schilk, Michael Henry
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Options
50 - Grant of options
|
$123,500
+650,000 vol $0.19 each |
800,000 | |
| Filed 2020-03-16 13:44 Tx date 2020-03-13 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$133,000
+700,000 vol $0.19 each |
1,137,004 | |
| Filed 2020-03-16 10:36 Tx date 2020-03-13 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$38,000
+200,000 vol $0.19 each |
373,100 | |
| Filed 2020-03-15 19:33 Tx date 2020-03-13 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$171,000
+900,000 vol $0.19 each |
1,850,000 | |
| Filed 2020-03-15 12:15 Tx date 2020-03-13 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$142,500
+750,000 vol $0.19 each |
2,150,000 | |
| Filed 2020-03-14 11:50 Tx date 2020-03-13 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$38,000
+200,000 vol $0.19 each |
600,000 | |
| Filed 2020-03-14 11:30 Tx date 2020-03-13 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$47,500
+250,000 vol $0.19 each |
500,000 | |
| Filed 2020-03-13 17:48 Tx date 2020-03-13 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$47,500
+250,000 vol $0.19 each |
1,250,000 | |
| Filed 2019-12-31 11:52 Tx date 2019-09-16 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$215,000
+500,000 vol $0.43 each |
1,400,000 | |
| Filed 2019-12-30 18:57 Tx date 2019-08-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-412,500
-150,000 vol $2.75 each |
950,000 | |
| Filed 2019-08-22 14:59 Tx date 2019-08-19 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
1,000,000 | |
| Filed 2019-08-22 14:58 Tx date 2019-08-19 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
900,000 | |
| Filed 2019-08-22 14:57 Tx date 2019-08-19 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
800,000 | |
| Filed 2019-08-22 14:57 Tx date 2019-08-19 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
700,000 | |
| Filed 2019-08-22 14:55 Tx date 2019-08-19 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
600,000 | |
| Filed 2019-08-22 14:54 Tx date 2019-08-19 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
| Filed 2019-08-22 14:48 Tx date 2019-08-16 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-04-01 Tx date 2019-03-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$99,999
+65,789 vol $1.52 each |
38,545,835 | |
| Filed 2019-04-01 Tx date 2019-03-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-99,999.28
-65,789 vol $1.52 each |
1,705,265 | |
| Filed 2019-03-18 Tx date 2019-03-15 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$249,998
+164,473 vol $1.52 each |
38,480,046 | |
| Filed 2019-03-18 Tx date 2019-03-15 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-249,998.96
-164,473 vol $1.52 each |
1,771,054 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$249,998
+164,473 vol $1.52 each |
38,315,573 | |
| Filed 2019-03-13 Tx date 2019-03-08 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-249,998.96
-164,473 vol $1.52 each |
1,935,527 | |
| Filed 2019-01-15 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Holder: Calista Herbst (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+100 vol |
||
| Filed 2019-01-15 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Holder: Soleil Herbst (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$152.00
+100 vol $1.52 each |
||
| Filed 2019-01-15 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Holder: Calista Herbst (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+100 vol |
||
| Filed 2019-01-15 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Holder: Soleil Herbst (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$152.00
+100 vol $1.52 each |
||
| Filed 2019-01-15 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$3,192,000
+2,100,000 vol $1.52 each |
2,100,000 | |
| Filed 2019-01-15 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Schilk, Michael Henry
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Options
50 - Grant of options
|
$228,000
+150,000 vol $1.52 each |
150,000 | |
| Filed 2019-01-15 Tx date 2018-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
52 - Expiration of options
|
-600,000 vol |
0 | |
| Filed 2019-01-15 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$456,000
+300,000 vol $1.52 each |
437,004 | |
| Filed 2019-01-15 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Holder: Kal Herbst (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+100 vol |
||
| Filed 2019-01-15 Tx date 2018-01-01 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Schilk, Michael Henry
8 - Deemed Insider - 6 Months before becoming Insider
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-15 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Holder: Kal Herbst (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+100 vol |
||
| Filed 2019-01-15 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$1,368,000
+900,000 vol $1.52 each |
900,000 | |
| Filed 2019-01-14 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,444,000
+950,000 vol $1.52 each |
1,100,000 | |
| Filed 2019-01-14 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$532,000
+350,000 vol $1.52 each |
250,000 | |
| Filed 2019-01-14 Tx date 2018-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-900,000
-600,000 vol $1.50 each |
150,000 | |
| Filed 2019-01-11 Tx date 2019-01-10 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$608,000
+400,000 vol $1.52 each |
400,000 | |
| Filed 2019-01-11 Tx date 2018-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-300,000
-200,000 vol $1.50 each |
0 | |
| Filed 2019-01-03 Tx date 2018-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$40,350
+26,900 vol $1.50 each |
161,900 | |
| Filed 2019-01-03 Tx date 2018-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$40,350
+26,900 vol $1.50 each |
||
| Filed 2019-01-03 Tx date 2018-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-40,350
-26,900 vol $1.50 each |
173,100 | |
| Filed 2019-01-03 Tx date 2018-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$40,350
+26,900 vol $1.50 each |
||
| Filed 2018-12-24 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2018-12-24 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2018-12-20 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
||
| Filed 2018-12-20 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
||
| Filed 2018-12-20 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
175,000 | |
| Filed 2018-12-20 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
275,000 | |
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$262,500
+175,000 vol $1.50 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
937,480 | |
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$20,000
+100,000 vol $0.20 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
837,480 | |
| Filed 2018-12-15 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$262,500
+175,000 vol $1.50 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$262,500
+175,000 vol $1.50 each |
1,012,480 | |
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$262,500
+175,000 vol $1.50 each |
1,012,480 | |
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2018-12-15 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$262,500
+175,000 vol $1.50 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
937,480 | |
| Filed 2018-12-15 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$262,500
+175,000 vol $1.50 each |
||
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
837,480 | |
| Filed 2018-12-15 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$20,000
+100,000 vol $0.20 each |
||
| Filed 2018-12-07 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
175,000 | |
| Filed 2018-12-07 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$-262,500
-175,000 vol $1.50 each |
175,000 | |
| Filed 2018-11-30 Tx date 2018-11-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$262,500
+175,000 vol $1.50 each |
450,000 | |
| Filed 2018-10-12 Tx date 2018-10-11 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$300,000
+200,000 vol $1.50 each |
38,151,100 | |
| Filed 2018-10-12 Tx date 2018-10-11 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-300,000
-200,000 vol $1.50 each |
0 | |
| Filed 2018-08-30 Tx date 2018-08-28 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-430,000
-200,000 vol $2.15 each |
20,000 | |
| Filed 2018-08-13 Tx date 2016-11-16 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,504
+8,800 vol $1.08 each |
240,000 | |
| Filed 2018-08-13 Tx date 2016-11-15 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$65,400
+60,000 vol $1.09 each |
231,200 | |
| Filed 2018-08-13 Tx date 2016-11-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,000
+10,000 vol $1.10 each |
171,200 | |
| Filed 2018-08-13 Tx date 2016-11-11 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,920
+27,200 vol $1.10 each |
161,200 | |
| Filed 2018-08-13 Tx date 2016-11-09 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,500
+25,000 vol $1.10 each |
134,000 | |
| Filed 2018-08-13 Tx date 2016-10-27 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,520
+19,000 vol $1.08 each |
109,000 | |
| Filed 2018-08-13 Tx date 2016-10-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+10,000 vol $1.05 each |
90,000 | |
| Filed 2018-06-13 Tx date 2018-06-11 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,919.60
-1,000 vol $1.92 each |
135,000 | |
| Filed 2018-06-04 Tx date 2018-06-01 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-965.00
-500 vol $1.93 each |
136,000 | |
| Filed 2018-06-04 Tx date 2018-05-31 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,865
-1,500 vol $1.91 each |
136,500 | |
| Filed 2018-05-29 Tx date 2018-05-24 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-957.80
-500 vol $1.92 each |
138,000 | |
| Filed 2018-05-29 Tx date 2018-05-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23.40
-12 vol $1.95 each |
138,500 | |
| Filed 2018-05-29 Tx date 2018-05-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-168.08
-88 vol $1.91 each |
138,512 | |
| Filed 2018-05-29 Tx date 2018-05-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-576.00
-300 vol $1.92 each |
138,600 | |
| Filed 2018-05-29 Tx date 2018-05-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-192.00
-100 vol $1.92 each |
138,900 | |
| Filed 2018-05-29 Tx date 2018-05-22 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-965.00
-500 vol $1.93 each |
139,000 | |
| Filed 2018-05-29 Tx date 2018-05-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-800.00
-400 vol $2.00 each |
139,500 | |
| Filed 2018-05-29 Tx date 2018-05-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-203.00
-100 vol $2.03 each |
139,900 | |
| Filed 2018-04-25 Tx date 2018-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
52 - Expiration of options
|
$-249,000
-996,000 vol $0.25 each |
600,000 | |
| Filed 2018-04-25 Tx date 2018-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-26,000
-104,000 vol $0.25 each |
1,596,000 | |
| Filed 2018-04-25 Tx date 2018-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$26,000
+104,000 vol $0.25 each |
1,459,580 | |
| Filed 2018-04-17 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
275,000 | |
| Filed 2018-04-17 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$20,000
+100,000 vol $0.20 each |
||
| Filed 2018-04-17 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,478
+1,300 vol $2.68 each |
677,480 | |
| Filed 2018-04-17 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,808
+1,300 vol $2.16 each |
||
| Filed 2018-04-17 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,528
+1,700 vol $2.66 each |
676,180 | |
| Filed 2018-04-17 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,655
+1,700 vol $2.15 each |
||
| Filed 2018-04-17 Tx date 2017-08-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,955
+5,000 vol $2.39 each |
674,480 | |
| Filed 2018-04-17 Tx date 2017-08-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,650
+5,000 vol $1.93 each |
||
| Filed 2018-04-17 Tx date 2017-08-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,254
+5,000 vol $2.25 each |
669,480 | |
| Filed 2018-04-17 Tx date 2017-08-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,150
+5,000 vol $1.83 each |
||
| Filed 2018-04-03 Tx date 2018-03-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,375,000
-500,000 vol $2.75 each |
1,700,000 | |
| Filed 2018-04-03 Tx date 2017-08-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$1,375,000
+500,000 vol $2.75 each |
2,200,000 | |
| Filed 2018-04-03 Tx date 2017-08-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$1,650,000
+600,000 vol $2.75 each |
||
| Filed 2018-04-03 Tx date 2018-03-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,375,000
+500,000 vol $2.75 each |
1,355,580 | |
| Filed 2018-04-02 Tx date 2018-03-26 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-35,000
-140,000 vol $0.25 each |
200,000 | |
| Filed 2018-04-02 Tx date 2018-03-26 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$35,000
+140,000 vol $0.25 each |
140,000 | |
| Filed 2018-04-02 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-02 Tx date 2018-03-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-173,239
-62,996 vol $2.75 each |
137,004 | |
| Filed 2018-04-02 Tx date 2017-08-09 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Holder: Soleil Herbst (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
1,000 | |
| Filed 2018-04-02 Tx date 2017-08-09 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Holder: Calista Herbst (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
||
| Filed 2018-04-02 Tx date 2017-08-09 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Holder: Calista Herbst (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
||
| Filed 2018-04-02 Tx date 2018-03-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$173,239
+62,996 vol $2.75 each |
62,996 | |
| Filed 2018-04-02 Tx date 2017-07-01 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-02 Tx date 2017-07-01 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-02 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-02 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2018-03-27 Tx date 2018-03-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
51 - Exercise of options
|
$20,000
+100,000 vol $0.20 each |
275,000 | |
| Filed 2018-03-16 Tx date 2018-03-13 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-44,000
-176,000 vol $0.25 each |
750,000 | |
| Filed 2018-03-16 Tx date 2018-03-13 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$44,000
+176,000 vol $0.25 each |
340,000 | |
| Filed 2018-01-31 Tx date 2018-01-26 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
200,000 | |
| Filed 2018-01-31 Tx date 2018-01-26 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
220,000 | |
| Filed 2018-01-09 Tx date 2018-01-08 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-31,000
-124,000 vol $0.25 each |
926,000 | |
| Filed 2018-01-09 Tx date 2018-01-08 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$31,000
+124,000 vol $0.25 each |
164,000 | |
| Filed 2018-01-03 Tx date 2017-12-18 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
51 - Exercise of options
|
-750,000 vol |
200,000 | |
| Filed 2018-01-03 Tx date 2017-12-18 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,125,000
+750,000 vol $1.50 each |
37,951,100 | |
| Filed 2017-11-20 Tx date 2017-11-01 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
-80,000 vol |
120,000 | |
| Filed 2017-09-08 Tx date 2017-08-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$1,650,000
+600,000 vol $2.75 each |
2,300,000 | |
| Filed 2017-09-01 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,808
+1,300 vol $2.16 each |
677,480 | |
| Filed 2017-09-01 Tx date 2017-08-25 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,655
+1,700 vol $2.15 each |
676,180 | |
| Filed 2017-09-01 Tx date 2017-08-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,650
+5,000 vol $1.93 each |
674,480 | |
| Filed 2017-09-01 Tx date 2017-08-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,150
+5,000 vol $1.83 each |
669,480 | |
| Filed 2017-08-30 Tx date 2017-08-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$11,910
+7,940 vol $1.50 each |
15,000 | |
| Filed 2017-08-30 Tx date 2017-08-29 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-11,910
-7,940 vol $1.50 each |
85,000 | |
| Filed 2017-08-19 Tx date 2017-08-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2017-08-19 Tx date 2017-07-01 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-18 Tx date 2017-08-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
DiMarzo, Robert Walter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$687,500
+250,000 vol $2.75 each |
850,000 | |
| Filed 2017-08-17 Tx date 2017-08-14 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$412,500
+150,000 vol $2.75 each |
1,050,000 | |
| Filed 2017-08-09 Tx date 2017-08-08 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-24,240
-10,100 vol $2.40 each |
37,201,100 | |
| Filed 2017-08-09 Tx date 2017-08-09 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Holder: Kal Herbst (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
1,000 | |
| Filed 2017-08-09 Tx date 2017-07-01 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Holder: Kal Herbst (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-09 Tx date 2017-08-09 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Holder: Calista Herbst (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
2,000 | |
| Filed 2017-08-09 Tx date 2017-08-09 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Holder: Calista Herbst (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
1,000 | |
| Filed 2017-08-09 Tx date 2017-07-01 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Holder: Calista Herbst (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-09 Tx date 2017-07-01 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Herbst, Bruk
5 - Senior Officer of Issuer
Holder: Soleil Herbst (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-03 Tx date 2017-08-03 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Nicholas Rampertab (Control or Direction)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
1,000 | |
| Filed 2017-08-03 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Nicholas Rampertab (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-03 Tx date 2017-08-03 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Jacob Rampertab (Control or Direction)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
1,000 | |
| Filed 2017-08-03 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Jacob Rampertab (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-03 Tx date 2017-08-03 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Amanda Rampertab (Control or Direction)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
1,000 | |
| Filed 2017-08-03 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Amanda Rampertab (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-03 Tx date 2017-08-03 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Mia Kay DeLaBarre (Control or Direction)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
1,000 | |
| Filed 2017-08-03 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Mia Kay DeLaBarre (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-03 Tx date 2017-08-03 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Josephine Cooper Morley (Control or Direction)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
1,000 | |
| Filed 2017-08-03 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Josephine Cooper Morley (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-03 Tx date 2017-08-03 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Jaxon Morgan DeLaBarre (Control or Direction)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
1,000 | |
| Filed 2017-08-03 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Jaxon Morgan DeLaBarre (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-03 Tx date 2017-08-03 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Charlotte Ray Morley (Control or Direction)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
1,000 | |
| Filed 2017-08-03 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Charlotte Ray Morley (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-03 Tx date 2017-08-03 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Brody Richard DeLaBarre (Control or Direction)
|
Common Shares
47 - Acquisition or disposition by gift
|
+1,000 vol |
1,000 | |
| Filed 2017-08-03 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Brody Richard DeLaBarre (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-10 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares Escrowed Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-10 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Gerald Solensky (Control or Direction)
|
Common Shares Escrowed Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-10 Tx date 2017-07-01 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-591,900 vol |
37,211,200 | |
| Filed 2017-07-10 Tx date 2017-07-01 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-100,000 vol |
37,803,100 | |
| Filed 2017-07-10 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
37,903,100 | ||
| Filed 2017-05-11 Tx date 2017-05-08 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$139,410
+92,940 vol $1.50 each |
||
| Filed 2017-05-11 Tx date 2017-05-08 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$139,410
+92,940 vol $1.50 each |
||
| Filed 2017-05-11 Tx date 2016-10-04 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
92,940 | ||
| Filed 2017-05-11 Tx date 2016-10-04 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-11 Tx date 2016-10-04 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-11 Tx date 2016-10-04 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-11 Tx date 2016-10-04 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-11 Tx date 2017-05-08 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$10,590
+7,060 vol $1.50 each |
7,060 | |
| Filed 2017-05-11 Tx date 2017-04-27 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$10,500
+7,000 vol $1.50 each |
||
| Filed 2017-05-11 Tx date 2016-10-04 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-27 Tx date 2017-04-27 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$10,500
+7,000 vol $1.50 each |
7,000 | |
| Filed 2017-04-27 Tx date 2016-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$150,000
+100,000 vol $1.50 each |
||
| Filed 2017-04-27 Tx date 2016-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$150,000
+100,000 vol $1.50 each |
||
| Filed 2017-04-27 Tx date 2016-10-04 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-02-28 Tx date 2017-02-17 |
$ZOM
Zomedica Pharmaceuticals Corp. |
DiMarzo, Robert Walter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
600,000 | ||
| Filed 2017-02-28 Tx date 2017-02-17 |
$ZOM
Zomedica Pharmaceuticals Corp. |
DiMarzo, Robert Walter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-02-28 Tx date 2017-02-17 |
$ZOM
Zomedica Pharmaceuticals Corp. |
DiMarzo, Robert Walter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
134,880 | ||
| Filed 2017-01-03 Tx date 2016-12-28 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
97 - Other
|
$876,720
+584,480 vol $1.50 each |
664,480 | |
| Filed 2017-01-02 Tx date 2016-10-04 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Eagleson, Jane Shirley
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2016-12-27 Tx date 2016-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$300,000
+200,000 vol $1.50 each |
300,000 | |
| Filed 2016-12-23 Tx date 2016-12-23 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$300,000
+200,000 vol $1.50 each |
340,000 | |
| Filed 2016-12-23 Tx date 2016-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$1,425,000
+950,000 vol $1.50 each |
950,000 | |
| Filed 2016-12-23 Tx date 2016-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$1,425,000
+950,000 vol $1.50 each |
||
| Filed 2016-12-23 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-23 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-23 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
175,000 | ||
| Filed 2016-12-23 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-23 Tx date 2016-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
1,700,000 | |
| Filed 2016-12-23 Tx date 2016-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
MacArthur, William Carpenter
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$600,000
+400,000 vol $1.50 each |
1,300,000 | |
| Filed 2016-12-22 Tx date 2016-12-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$900,000
+600,000 vol $1.50 each |
900,000 | |
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Williams, Rodney
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
140,000 | ||
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Rowe Family GST (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
11,120,000 | ||
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Rowe Family GST (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+1,100,000 vol |
1,100,000 | |
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$12,979
+259,580 vol $0.05 each |
||
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$12,979
+259,580 vol $0.05 each |
||
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$12,979
+259,580 vol $0.05 each |
||
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
50 - Grant of options
|
$275,000
+1,100,000 vol $0.25 each |
||
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
50 - Grant of options
|
$275,000
+1,100,000 vol $0.25 each |
||
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
50 - Grant of options
|
$275,000
+1,100,000 vol $0.25 each |
||
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
855,580 | ||
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-05 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
MacArthur, William Carpenter
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
900,000 | ||
| Filed 2016-05-04 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2016-05-04 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rampertab, Shameze
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
40,000 | ||
| Filed 2016-05-04 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
MacArthur, William Carpenter
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,374,740 | ||
| Filed 2016-04-30 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2016-04-30 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
LeBar, James Melvin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2016-04-28 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$12,979
+259,580 vol $0.05 each |
1,915,580 | |
| Filed 2016-04-28 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
50 - Grant of options
|
$275,000
+1,100,000 vol $0.25 each |
1,656,000 | |
| Filed 2016-04-28 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Morley, Stephanie
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
556,000 | ||
| Filed 2016-04-27 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Solensky, Gerald L. Solensky Jr.
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Gerald Solensky (Control or Direction)
|
Common Shares Escrowed Shares
00 - Opening Balance-Initial SEDI Report
|
37,903,100 | ||
| Filed 2016-04-27 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-27 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-27 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
80,000 | ||
| Filed 2016-04-27 Tx date 2016-04-21 |
$ZOM
Zomedica Pharmaceuticals Corp. |
Rowe, Jeffrey Mark
6 - Director or Senior Officer of 10% Security Holder
Holder: Rowe Family GST (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,112,000 |